Schizophrenia & Psychosis
Search All News
Dr. Joshua Kantrowitz discusses a recent trial of CVN058, a drug that may reduce cognitive impairments in individuals with schizophrenia.
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation
- February 20, 2019
Patients with schizophrenia are often treated with more than one type of psychiatric medication, but a new study suggests that some combinations may be more effective than others.
- February 19, 2019
Researchers have developed a practical and accurate self-report screener for detecting early psychosis and enabling early treatment.
Source:Psychiatry AdvisorSeptember 6, 2018
Dr. Lisa B. Dixon discusses early intervention in schizophrenia.
Source:Scientific AmericanMay 30, 2018
Dr. Alan Brown said that "the recognition that environmental factors in early development, prenatal factors, are likely to be very important in schizophrenia and just as important as genes,” is key.
- May 23, 2018
Dr. Ilana Nossel is the medical director and co-associate director of OnTrackNY and an assistant professor of clinical psychiatry at Columbia University Irving Medical Center (CUIMC).
- April 30, 2018
A new study suggests that when a specific approach to supported employment (Individual Placement and Support) is implemented well it is associated with higher employment rates sustained over time.
Source:Washington PostApril 6, 2018
Initially, Seroquel seemed to have few side effects or complications. “The risks are far greater than I think has been represented,” said Dr. Mark Olfson.
- February 16, 2018
Researchers at Columbia Universityand New York State Psychiatric Institute (NYSPI) found that people with schizophrenia who experience auditory hallucinations tend to hear what they expect.
Source:Medical XpressNovember 29, 2017
"These results enable us to determine whether potential treatments will be effective against patients' symptoms by testing them first in healthy volunteers," said Dr. Jeffrey Lieberman.